Polyethylene Wear Particle Analysis of THA
1 other identifier
observational
90
2 countries
2
Brief Summary
Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior to conventional polyethylene in vivo. The aim of this project is to conduct an international multi-center joint research study to determine whether polyethylene wear debris production can be reduced in the future, using an in vivo polyethylene wear debris analysis method that the investigators developed as a method that can provide early feedback.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2024
CompletedFirst Posted
Study publicly available on registry
May 29, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
January 20, 2025
January 1, 2025
3.6 years
May 16, 2024
January 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of polyethylene wear particles
counts / g (tissue sample)
When tissue sample was collected during THA revision surgery
Equivalent circle diameter of polyethylene wear particles
equivalent circle diameter \[㎛\]
When tissue sample was collected during THA revision surgery
Aspect ratio of polyethylene wear particles
aspect ratio
When tissue sample was collected during THA revision surgery
Roundness of polyethylene wear particles
roundness
When tissue sample was collected during THA revision surgery
Secondary Outcomes (8)
Body mass index
When tissue sample was collected during THA revision surgery
Hip joint flexion angle
When tissue sample was collected during THA revision surgery
Hip joint exertion angle
When tissue sample was collected during THA revision surgery
Hip joint adduction angle
When tissue sample was collected during THA revision surgery
Hip joint abduction angle
When tissue sample was collected during THA revision surgery
- +3 more secondary outcomes
Study Arms (3)
polyethylene containing Vitamin E
polyethylene containing Vitamin E
conventional polyethylene (no highly cross-linking)
conventional polyethylene (no highly cross-linking)
conventional polyethylene (with highly cross-linking)
conventional polyethylene (with highly cross-linking)
Interventions
No intervention as this is an observational study
Eligibility Criteria
Patients undergoing revision hip arthroplasty within the study period
You may qualify if:
- Patients undergoing revision hip arthroplasty within the study period
- Patients over 20 years old
- Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
- Patients who have passed 2 years or more since their first total hip arthroplasty
You may not qualify if:
- \. Patients who are judged to be unsuitable as research subjects by the research physician
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Osaka Metropolitan Universitylead
- Mayo Cliniccollaborator
- Hospital for Special Surgery, New Yorkcollaborator
- Istituto Ortopedico Rizzolicollaborator
Study Sites (2)
Mayo Clinic
Rochester, Minnesota, 55905, United States
Osaka Metropolitan University
Osaka, 5458585, Japan
Related Publications (3)
Iwakiri K, Iwaki H, Kobayashi A, Minoda Y, Kagiyama H, Kadoya Y, Takaoka K. Characteristics of Hylamer polyethylene particles isolated from peri-prosthetic tissues of failed cemented total hip arthroplasties. J Biomed Mater Res B Appl Biomater. 2008 Apr;85(1):125-9. doi: 10.1002/jbm.b.30924.
PMID: 17806109RESULTHata K, Minoda Y, Ikebuchi M, Mizokawa S, Ohta Y, Miyazaki N, Miyake Y, Nakamura H. In vivo wear particles of remelted highly crosslinked polyethylene after total hip arthroplasty: report of four cases. J Mater Sci Mater Med. 2015 Mar;26(3):133. doi: 10.1007/s10856-015-5472-9. Epub 2015 Feb 25.
PMID: 25712074RESULTMinoda Y, Kobayashi A, Sakawa A, Aihara M, Tada K, Sugama R, Iwakiri K, Ohashi H, Takaoka K. Wear particle analysis of highly crosslinked polyethylene isolated from a failed total hip arthroplasty. J Biomed Mater Res B Appl Biomater. 2008 Aug;86(2):501-5. doi: 10.1002/jbm.b.31048.
PMID: 18360879RESULT
Biospecimen
The pericapsular tissue, which is removed during surgery
Study Officials
- PRINCIPAL INVESTIGATOR
Yukihide Minoda, MD, PhD
Osaka Metropolitan University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 16, 2024
First Posted
May 29, 2024
Study Start
June 1, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
January 20, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share